手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| Clarke Hypoglycemia Awareness Questionnaire× | ThyPRO: 甲状腺関連患者報告アウトカム尺度× | |
|---|---|---|
| 分野 | 内分泌学 | 内分泌学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 1995 | 2009 |
| 提唱者≠ | William L. Clarke, Don J. Cox, Lois A. Gonder-Frederick | Torquil Watt, Jens Bjørner, Marianne Groenvold |
| 種類 | Patient self-report questionnaire | Patient self-report questionnaire |
| 原典≠ | Clarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995). Reduced awareness of hypoglycemia in adults with IDDM: A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care, 18(6), 517-522. DOI ↗ | Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580. link ↗ |
| 別名≠ | HAQ, Clarke HAQ, Hypoglycemia Awareness Scale | ThyPRO-85, ThyPRO-39 |
| 関連 | 3 | 3 |
| 概要≠ | The Clarke Hypoglycemia Awareness Questionnaire is an 8-item instrument designed to identify patients with impaired hypoglycemia awareness—a condition in which diabetic patients fail to perceive early warning symptoms of low blood glucose, substantially increasing their risk of severe hypoglycemia. Developed by Clarke and colleagues in 1995, it is the most widely used screening tool for this dangerous complication in type 1 diabetes and in insulin-treated type 2 diabetes populations. | ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer. |
| ScholarGateデータセット ↗ |
|
|